IZAFE B — iZafe AB Share Price
Last trade - 00:00- SEK71.10m
- SEK75.54m
- SEK7.95m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.31 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 8.94 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -199.68% | ||
| Return on Equity | -116.92% | ||
| Operating Margin | -244.22% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 8.9 | 0.44 | 0.73 | 1.82 | 7.95 | 20 | 37 | -11.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
iZafe Group AB is a Sweden-based medical technology company that develops and markets medical and digital safety solutions to create safer medication management at home. The Company's focus is on providing products and services that enhance medication safety and improve the overall well-being of individuals. It is engaged in the development of digital drug dispensing through the pharmaceutical robot Dosell as well as The Software as a service (SaaS) solution with the connected dose bag Pillbox. The company's solutions reduce the risk of incorrect medication in the home, public care, increases the quality of life for patients and creates a safer environment for relatives. The customers are private individuals, pharmaceutical companies and public and private healthcare providers.
Directors
- Thomas Ahlerup CHM
- Anders Segerstrom CEO
- Tobias Johansson DCE
- Ida Almgren CFO
- Goran Hermanson COO
- Viveca Gyberg DRC
- Carl Sjonell DRC (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 11th, 2008
- Public Since
- April 4th, 2011
- No. of Employees
- 7
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 275,586,171
- Address
- David bagares gata 3, STOCKHOLM, 111 38
- Web
- https://izafe.se/
- Phone
- +46 8211121
- Contact
- Anders Segerstrom
- Auditors
- Johan Kaijser
Upcoming Events for IZAFE B
Similar to IZAFE B
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 20:24 UTC, shares in iZafe AB are trading at SEK0.26. This share price information is delayed by 15 minutes.
Shares in iZafe AB last closed at SEK0.26 and the price had moved by +8.4% over the past 365 days. In terms of relative price strength the iZafe AB share price has underperformed the FTSE Global All Cap Index by -0.23% over the past year.
There is no consensus recommendation for this security.
Find out moreiZafe AB does not currently pay a dividend.
iZafe AB does not currently pay a dividend.
iZafe AB does not currently pay a dividend.
To buy shares in iZafe AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.26, shares in iZafe AB had a market capitalisation of SEK71.10m.
Here are the trading details for iZafe AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: IZAFE B
Based on an overall assessment of its quality, value and momentum iZafe AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in iZafe AB is SEK0.28. That is 8.53% above the last closing price of SEK0.26.
Analysts covering iZafe AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.10 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like iZafe AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +13%.
As of the last closing price of SEK0.26, shares in iZafe AB were trading +15.74% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The iZafe AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
iZafe AB's management team is headed by:
- Thomas Ahlerup - CHM
- Anders Segerstrom - CEO
- Tobias Johansson - DCE
- Ida Almgren - CFO
- Goran Hermanson - COO
- Viveca Gyberg - DRC
- Carl Sjonell - DRC